Oncología

Resultados: 378
Tipo Título / Nombre Autor(es) Año
Rendimiento diagnóstico de un panel de genes en el estudio de rutina de los síndromes de cáncer hereditario Romero Chala S, González Santiago S, López Ceballos MH, López Gallego J, Vergara Prieto E, Sobieschi OI, et al 2023
Compresión Medular en paciente diagnosticado de Carcinoma Microcítico de Pulmón con antecedentes personales de Síndrome de POEMS Espacio Santos PM 2023
Real-World Efficacy of Atezolizumab in Patients with Previously Treated Advanced NSCLC in Spain - TRACKER Study Carcereny E, Padilla A, Rodríguez García JM, Córdoba JF, Esteban E, et al 2023
Problemas éticos en la comunicación del pronóstico a pacientes oncológicos. Autonomía Vs bienestar. Datos del estudio NEOetic García García T, Jiménez Fonseca P, Galán Moran R, Hernández Gil..., López de Ceballos Reyna H 2023
Sex differences in advanced melanoma in Spain: Results from the prospective real-world study GEM 1801 Muñoz Couselo E, Berciano Guerrero MA, Manzano JL..., Ayala de Miguel P 2023
Characterization of melanoma of unknown primary in the era of immunotherapy and targeted therapy in Spain: Results from the prospective real-world study GEM 1801 Cerezuela Fuentes P, Piñero Madrona A, Muñoz Couselo E..., Ayala de Miguel P 2023
Long-term benefit of atezolizumab plus chemotherapy in extensive stage small cell lung cancer (ES-SCLC): Exploratory analysis from the IMfirst study García Campelo MR, Dómine M, Castro Carpeño J de. Moreno Vega AL..., Alonso Calderón R 2023
Encorafenib (E) plus binimetinib (B) in unresectable advanced or metastatic BRAFV600-mut melanoma, realworld evidence in Spain (GEM 2002 - BECARE) Soria A, Sánchez Mauriño P, García Galindo R..., Ayala de Miguel P 2023
Tolerability and effectiveness of niraparib in long-term responders with platinum-sensitive recurrent ovarian cancer (GEICO-88R study) Cueva Banuelos JF, Salvador Coloma C, Gálvez Montosa F..., González Santiago S 2023
PROSTRATEGY: A SOGUG randomized trial of androgen deprivation therapy (ADT) plus docetaxel (dct) +/- nivolumab (nivo) or ipilimumab-nivolumab (ipi-nivo) in high-volume metastatic hormone-sensitive prostate cancer (hvHSPCa) - Efficacy results from the pilot phase Arranz Arija JA, Piulats Rodríguez JM, Vázquez Estévez S..., Martín RC 2023